New pharmacotherapy options for chemotherapy-induced alimentary mucositis

Bibliography

• Sonis ST. Oral mucositis in cancer therapy. J Support Oncol 2004;2:3-8
   PubMedGoogle Scholar
• Sonis ST. A biological approach to mucositis. J Support Oncol 2004;2:21-32; discussion 5-6
   PubMedGoogle Scholar
• Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 2004;4:277-84
   PubMed Web of Science ®Google Scholar
• Bowen JM, Elad S, Hutchins RD, Lalla RV. Methodology for the MASCC/ISOO mucositis clinical practice guidelines update. Support Care Cancer 2013;21:303-8
   PubMed Web of Science ®Google Scholar
• Gibson RJ, Cummins AG, Bowen JM, et al. Apoptosis occurs early in the basal layer of the oral mucosa following cancer chemotherapy. Asia Pac J Clin Oncol 2006;2:39-49
   Google Scholar
• Blijlevens NM, Donnelly JP, De Pauw BE. Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 2000;25:1269-78
   PubMed Web of Science ®Google Scholar
• Stringer AM, Al-Dasooqi N, Bowen JM, et al. Potential biomarkers of chemotherapy-induced diarrhea: a clinical study of intestinal microbiome alterations; intestinal inflammation and circulating matrix metalloproteinases. Support Care Cancer 2013;21:1843-52
   PubMed Web of Science ®Google Scholar
• Stringer AM, Gibson RJ, Bowen JM, et al. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. Int J Exp Pathol 2009;90:489-99
   PubMed Web of Science ®Google Scholar
• Stringer AM, Gibson RJ, Logan RM, et al. Irinotecan-induced mucositis is associated with changes in intestinal mucins. Cancer Chemother Pharmacol 2009;64:123-32
   PubMed Web of Science ®Google Scholar
• Elting LS, Cooksley C, Chambers M, et al. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2003;98:1531-9
   PubMed Web of Science ®Google Scholar
• Gibson RJ, Keefe DM, Lalla RV, et al. Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer 2013;21:313-26
   PubMed Web of Science ®Google Scholar
• Somerfield MR, Padberg J, Pfister DG. ASCO clinical practice guidelines: process, progress, pitfalls and prospects. Classic Papers Curr Comments 2000;4:5
   Google Scholar
• Hadorn DC, Baker D, Hodges JS, Hicks N. Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol 1996;49:749-54
   PubMed Web of Science ®Google Scholar
• Andrews M, Gallagher-Allred C. The role of zinc in wound healing. Adv Wound Care 1999;12:137-8
   PubMedGoogle Scholar
• Maitra AK, Dorani B. Role of zinc in post-injury wound healing. Arch Emerg Med 1992;9:122-4
   PubMedGoogle Scholar
• Thompson C, Fuhrman MP. Nutrients and wound healing: still searching for the magic bullet. Nutr Clin Pract 2005;20:331-47
   PubMedGoogle Scholar
• Al-Dasooqi N, Sonis ST, Bowen JM, et al. Emerging evidence on the pathobiology of mucositis. Support Care Cancer 2013;21(11):3233-41
   PubMed Web of Science ®Google Scholar
• Mehdipour M, Taghavi Zenoz A, Asvadi Kermani I, Hosseinpour A. A comparison between zinc sulfate and chlorhexidine gluconate mouthwashes in the prevention of chemotherapy-induced oral mucositis. Daru 2011;19:71-3
   Google Scholar
• Arbabi-kalati F, Deghatipour M, Ansari Moghadam A. Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: a double-blind randomized clinical trial. Arch Iran Med 2012;15:413-17
   PubMed Web of Science ®Google Scholar
• Jensen SB, Pedersen AM, Vissink A, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer 2010;18:1061-79
   PubMed Web of Science ®Google Scholar
• Mansouri A, Hadjibabaie M, Iravani M, et al. The effect of zinc sulfate in the prevention of high-dose chemotherapy-induced mucositis: a double-blind, randomized, placebo-controlled study. Hematol Oncol 2012;30:22-6
   PubMed Web of Science ®Google Scholar
• Raber-Durlacher JE, von Bultzingslowen I, Logan RM, et al. Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer 2013;21:343-55
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S, Trent J, Patel S, et al. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial. Ann Intern Med 2010;153:358-67
   PubMed Web of Science ®Google Scholar
• Goldberg JD, Zheng J, Castro-Malaspina H, et al. Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants. Bone Marrow Transplant 2013;48:99-104
   PubMed Web of Science ®Google Scholar
• Blijlevens N, de Chateau M, Krivan G, et al. In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden. Bone Marrow Transplant 2013;48:966-71
   PubMed Web of Science ®Google Scholar
• Osterlund P, Ruotsalainen T, Korpela R, et al. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer 2007;97:1028-34
   PubMed Web of Science ®Google Scholar
• Abd El-Atti S, Wasicek K, Mark S, Hegazi R. Use of probiotics in the management of chemotherapy-induced diarrhea: a case study. JPEN J Parenter Enteral Nutr 2009;33:569-70
   PubMed Web of Science ®Google Scholar
• Stringer AM, Gibson RJ, Bowen JM, et al. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. Int J Exp Pathol 2009;90:489-99
   PubMed Web of Science ®Google Scholar
• Stringer AM, Gibson RJ, Logan RM, et al. Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the DA rat. Exp Biol Med (Maywood) 2007;232:96-106
   PubMed Web of Science ®Google Scholar
• Bowen JM, Stringer AM, Gibson RJ, et al. VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biol Ther 2007;6:1449-54
   PubMed Web of Science ®Google Scholar
• Prisciandaro LD, Geier MS, Butler RN, et al. Evidence supporting the use of probiotics for the prevention and treatment of chemotherapy-induced intestinal mucositis. Crit Rev Food Sci Nutr 2011;51:239-47
   PubMed Web of Science ®Google Scholar
• Prisciandaro LD, Geier MS, Butler RN, et al. Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats. Cancer Biol Ther 2011;11:671-7
   PubMed Web of Science ®Google Scholar
• Wang H, Brook CL, Whittaker AL, et al. Effects of Streptococcus thermophilus TH-4 in a rat model of doxorubicin-induced mucositis. Scand J Gastroenterol 2013;48:959-68
   PubMed Web of Science ®Google Scholar
• Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-33
   PubMed Web of Science ®Google Scholar
• Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 2001;120:622-35
   PubMed Web of Science ®Google Scholar
• Holmberg J, Genander M, Halford MM, et al. EphB receptors coordinate migration and proliferation in the intestinal stem cell niche. Cell 2006;125:1151-63
   PubMed Web of Science ®Google Scholar
• Kim KA, Kakitani M, Zhao J, et al. Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science 2005;309:1256-9
   PubMed Web of Science ®Google Scholar
• Abraham C, Cho JH. Inducing intestinal growth. N Engl J Med 2005;353:2297-9
   PubMed Web of Science ®Google Scholar
• Bhanja P, Saha S, Kabarriti R, et al. Protective role of R-spondin1, an intestinal stem cell growth factor, against radiation-induced gastrointestinal syndrome in mice. PLoS One 2009;4:e8014
   PubMed Web of Science ®Google Scholar
• Zhao J, Kim KA, De Vera J, et al. R-Spondin1 protects mice from chemotherapy or radiation-induced oral mucositis through the canonical Wnt/beta-catenin pathway. Proc Natl Acad Sci USA 2009;106:2331-6
   PubMed Web of Science ®Google Scholar
• Zhou WJ, Geng ZH, Spence JR, Geng JG. Induction of intestinal stem cells by R-spondin 1 and Slit2 augments chemoradioprotection. Nature 2013;501:107-11
   Google Scholar
• Laskowitz DT, Lei B, Dawson HN, et al. The apoE-mimetic peptide, COG1410, improves functional recovery in a murine model of intracerebral hemorrhage. Neurocrit Care 2012;16:316-26
   PubMed Web of Science ®Google Scholar
• Laskowitz DT, McKenna SE, Song P, et al. COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury. J Neurotrauma 2007;24:1093-107
   PubMed Web of Science ®Google Scholar
• Wang H, Durham L, Dawson H, et al. An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction. Neuroscience 2007;144:1324-33
   PubMed Web of Science ®Google Scholar
• Azevedo OG, Oliveira RA, Oliveira BC, et al. Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis. BMC Gastroenterol 2012;12:35
   PubMedGoogle Scholar
• Hausmann M, Obermeier F, Schreiter K, et al. Cathepsin D is up-regulated in inflammatory bowel disease macrophages. Clin Exp Immunol 2004;136:157-67
   PubMed Web of Science ®Google Scholar
• Menzel K, Hausmann M, Obermeier F, et al. Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo. Clin Exp Immunol 2006;146:169-80
   PubMed Web of Science ®Google Scholar
• Leblond J, Le Pessot F, Hubert-Buron A, et al. Chemotherapy-induced mucositis is associated with changes in proteolytic pathways. Exp Biol Med (Maywood) 2008;233:219-28
   PubMed Web of Science ®Google Scholar
• Alamir I, Boukhettala N, Aziz M, et al. Beneficial effects of cathepsin inhibition to prevent chemotherapy-induced intestinal mucositis. Clin Exp Immunol 2010;162:298-305
   PubMed Web of Science ®Google Scholar
• Molan PC. Potential of honey in the treatment of wounds and burns. Am J Clin Dermatol 2001;2:13-19
   PubMedGoogle Scholar
• Rashad UM, Al-Gezawy SM, El-Gezawy E, Azzaz AN. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer. J Laryngol Otol 2009;123:223-8
   PubMed Web of Science ®Google Scholar
• Abdulrhman M, El Barbary NS, Ahmed Amin D, Saeid Ebrahim R. Honey and a mixture of honey, beeswax, and olive oil-propolis extract in treatment of chemotherapy-induced oral mucositis: a randomized controlled pilot study. Pediatr Hematol Oncol 2012;29:285-92
   PubMed Web of Science ®Google Scholar
• Hawley P, Hovan A, McGahan CE, Saunders D. A randomized placebo-controlled trial of manuka honey for radiation-induced oral mucositis. Support Care Cancer 2013, doi:10.1007/s00520-0136-2031-0
   Google Scholar
• Whitehouse MW, Turner AG, Davis CK, Roberts MS. Emu oil(s): a source of non-toxic transdermal anti-inflammatory agents in aboriginal medicine. Inflammopharmacology 1998;6:1-8
   PubMedGoogle Scholar
• Lindsay RJ, Geier MS, Yazbeck R, et al. Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis. Br J Nutr 2010;104:513-19
   PubMed Web of Science ®Google Scholar
• Mashtoub S, Tran CD, Howarth GS. Emu oil expedites small intestinal repair following 5-fluorouracil-induced mucositis in rats. Exp Biol Med (Maywood) 2013;238(11):1305-17
   PubMed Web of Science ®Google Scholar